COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Urological Physical Therapy in HTLV-1 With Urinary Symptoms (UROHTLV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01651819
Recruitment Status : Completed
First Posted : July 27, 2012
Last Update Posted : October 5, 2018
Information provided by (Responsible Party):
ROSANA CRISTINA PEREIRA DE ANDRADE, Hospital Universitário Professor Edgard Santos

Brief Summary:
Urological physical therapy is described to improve urinary symptoms in patients with myelopathy or neurological dysfunction and to increase the quality of life. Although it was never tested on HTLV-1 associated overactive bladder syndrome, an disabling disease that is common seen in HAM/TSP patients but can also appear as an isolated form. Our hypothesis is that urological physical therapy can improve urinary symptoms like incontinence, urgency and nocturia in HTLV-1 infected population with those complains.

Condition or disease Intervention/treatment Phase
Tropical Spastic Paraparesis HTLV-1 Procedure: Urological physical therapy Not Applicable

Detailed Description:

The T-lymphotropic virus type 1 (HTLV-1) is an human retrovirus that was proved to be the main agent of the acute T cell lymphoma/leukemia (ATLL) and a progressive neurological disease called HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP).

The HTLV-1 was first isolated in 1980 and it is endemic in Japan, Caribbean, Africa and South America. It is estimated that about 20 million people is infected worldwide. In Brazil it is present in all states with variable prevalences. The factors associated with HTLV-1 transmission in Brazil are related to the social and demographic condition, characterized by rural exodus and increase of urban population in the coast areas.

Several studies based in Brazil reported that the epicenter of HTLV-1 infection is on Bahia, Maranhão and Pernambuco with the highest prevalence of 1,8% in Salvador, Bahia capital.

The urinary incontinence is a bladder-sphincter disturbance often found in HTLV-1 patients. In this infection the most common pathology finding is overactive bladder syndrome due detrusor overactivity and sphincter-detrusor dyssynergia and the symptoms are urgency, nocturia and incontinence.

This disabling disease is associated with psychosocial issues like loss of self confidence, social isolation and reduced quality of life.

The physical therapy treatment have the objective of promote social adequacy and reestablish the bladder function. It is based on resources like: bladder reeducation, biofeedback, kinesiotherapy of the pelvic wall, utilization of vaginal cones and electrostimulation.

Those can be associated or not with anticholinergic drugs and bladder catheterization.

The need of urologic and gynecologic physical therapy follow up in patients with HTLV-1 and neurogenic bladder is important to reduce disability, preserve pelvic muscles and renal function.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1
Actual Study Start Date : March 1, 2012
Actual Primary Completion Date : December 30, 2014
Actual Study Completion Date : July 30, 2015

Arm Intervention/treatment
Experimental: Urological physical therapy
Urologic physical therapy is going to be apply in 20 patients with HTLV-1 infection and overactive bladder symptoms like urgency, incontinence and nocturia. There will be 20 sessions with one hour duration and a interval of 3 or 4 days between the sections.
Procedure: Urological physical therapy
Individual patient attending with one hour duration beginning with Behavior therapy and education, teaching urinary maneuvers, water adequate intake. Second part is manual therapy an Kinesiotherapy with specific exercises, followed by patient repetition. Last part is constituted by electrotherapy for specific muscle stimulation and biofeedback.
Other Names:
  • Electrotherapy;
  • Behavior therapy;
  • Manual therapy;
  • Kinesiotherapy.

Primary Outcome Measures :
  1. Reduction in urinary symptoms [ Time Frame: 6 months ]
    reduce or cure the complaints of urinary symptoms measured by daily and nocturnal frequency, presence of incontinence, urgency, dysuria.

Secondary Outcome Measures :
  1. Improve in quality of life [ Time Frame: 6 months ]
    improving the quality of life measured by King' Health scale that is applied before and after therapy

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with HTLV-1 with more than 18 years and neurogenic bladder defined by urodynamic study.

Exclusion Criteria:

  • Diabetes Mellitus,
  • Stroke,
  • Multiple Sclerosis,
  • Parkinson disease,
  • use of pacemaker,
  • urinary infection.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01651819

Layout table for location information
Hospital Universitário Prof. Edgard Santos
Salvador, Bahia, Brazil
Sponsors and Collaborators
Hospital Universitário Professor Edgard Santos
Layout table for investigator information
Principal Investigator: Rosana Andrade, Master Federal University of Bahia
Layout table for additonal information
Responsible Party: ROSANA CRISTINA PEREIRA DE ANDRADE, coordenadora do Ambulatório de Fisioterapia Nas Disfunções perineias, Hospital Universitário Professor Edgard Santos Identifier: NCT01651819    
Other Study ID Numbers: ROAND2012
First Posted: July 27, 2012    Key Record Dates
Last Update Posted: October 5, 2018
Last Verified: October 2018
Keywords provided by ROSANA CRISTINA PEREIRA DE ANDRADE, Hospital Universitário Professor Edgard Santos:
neurogenic bladder
physical therapy
Tropical Spastic Paraparesis
Additional relevant MeSH terms:
Layout table for MeSH terms
Paraparesis, Tropical Spastic
Muscle Spasticity
Paraparesis, Spastic
Muscular Diseases
Musculoskeletal Diseases
Muscle Hypertonia
Neuromuscular Manifestations
Neurologic Manifestations
Nervous System Diseases
HTLV-I Infections
Deltaretrovirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Central Nervous System Infections
Central Nervous System Diseases
Spinal Cord Diseases